Genmab A/S
GMAB • Biotechnology
$33.60
▼ -0.81 (-2.35%)
Current price
EarningsLatest report: Mar 31, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$21.46B
Growth
—
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 25.9%Positive free cash flow · 1.85Consistent free cash flow · 5/5Reasonable earnings multiple · 19.86Healthy liquidity · 2.02
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 7, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$33.60
Change-2.35%
Shares Out638.55M
Market Cap$21.46B
Enterprise Value$25.16B
52W Range20.23 - 35.43
Beta0.68
P/E26.13
P/S5.50
P/B3.78
P/FCF24.62
EV/Sales6.45
Price$33.60
Change-2.35%
Shares Out638.55M
Market Cap$21.46B
Enterprise Value$25.16B
52W Range20.23 - 35.43
Beta0.68
P/E26.13
P/S5.50
P/B3.78
P/FCF24.62
EV/Sales6.45
EV/EBITDA17.73
EV/FCF28.88
Earnings Yield3.83%
FCF Yield4.06%
Dividend Yield0.00%
Gross Margin91.69%
Oper. Margin33.60%
Profit Margin25.89%
Debt/Eq0.93
Current Ratio2.02
Quick Ratio2.01
Target$38.25
Target Upside13.84%
Target Median$39.00
Target Range32.00 - 43.00
Volume2.01M
Avg Volume1.79M
EPS Surprise0.00
Investment DNA
How strong this company looks for long-term investors
69
out of 100
Business Quality
Margins, moat, returns
77/100
Financial Strength
Debt, cash, stability
88/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
68/100
Why this score▼
Stable or improving margins · 25.9%Positive free cash flow · 1.85Consistent free cash flow · 5/5Reasonable earnings multiple · 19.86Healthy liquidity · 2.02Negative growth trend
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 18 analyst votes · 2026-09-05
83/100
Bullish
Bullish
13
Hold
4
Bearish
1
Price Target
2026-08-07
Low
$32.00
Mean
$39.08
Median
$40.00
High
$43.00
🧾
No insider activity
No recent insider transactions available.